Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 22, 2022 - Issue 11-12
Submit an article Journal homepage
233
Views
0
CrossRef citations to date
0
Altmetric
Review

Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper

Flavio Villania Division of Clinical Neurophysiology and Epilepsy Center, IRCCS Ospedale Policlinico San Martino, Genoa, ItalyView further author information
,
Vittoria Ciancib Regional Epilepsy Centre, Great Metropolitan Hospital, Bianchi-Melacrino Morelli, Reggio, ItalyView further author information
,
Carlo Di Bonaventurac Epilepsy Centre, Department of Human Neurosciences, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Giancarlo Di Gennarod NEUROMED, IRCCS, Pozzilli, Isernia, ItalyView further author information
,
Carlo Andrea Galimbertie Epilepsy Center, Mondino Foundation, IRCCS, Pavia, ItalyView further author information
,
Renzo Guerrinif Neuroscience Department, Children’s Hospital A. Meyer-University of Florence, ItalyORCID Iconhttps://orcid.org/0000-0002-7272-7079View further author information
ORCID Icon,
Angela La Neveg Department of Basic Medical Sciences, Neurosciences and Sense Organs, University Hospital of Bari “A. Moro”, Bari, ItalyView further author information
,
Oriano Mecarellih Department of Human Neurosciences, Policlinico Umberto I, Sapienza University of Rome, Rome, ItalyView further author information
,
Nicola Pietrafusai Department of Neuroscience, Bambino Gesù Children’s Hospital, IRCCS, Rome, ItalyCorrespondence[email protected]
View further author information
,
Nicola Specchioi Department of Neuroscience, Bambino Gesù Children’s Hospital, IRCCS, Rome, ItalyView further author information
,
Federico Vigevanoi Department of Neuroscience, Bambino Gesù Children’s Hospital, IRCCS, Rome, ItalyView further author information
&
Emilio Peruccaj Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy, Department of Medicine (Austin Health), University of Melbourne, and Department of Neuroscience, Monash University, Melbourne, AustraliaView further author information
 show all
Pages 935-940 | Received 13 Apr 2022, Accepted 17 Jan 2023, Published online: 24 Jan 2023

References

  • Perucca E, Brodie MJ, Kwan P, et al. 30 years of second-generation antiseizure medications: impact and future perspectives. Lancet Neurol. 2020;19(6):544–556.
  • Xcopri. Prescribing information. cited Nov 16, 2021. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212839s000lbl.pdf
  • European Medicine Agency Cenobamate authorization [cited 2021 Dec 22]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/ontozry
  • Krauss GL, Klein P, Brandt C, et al. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. Lancet Neurol. 2020 Jan;19(1):38–48. [published correction appears in Lancet Neurol. 2020;19(3):e3.
  • Chung SS, French JA, Kowalski J, et al. Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures. Neurology. 2020;94(22):e2311–e2322.
  • Löscher W, Sills GJ, White HS. The ups and downs of alkyl-carbamates in epilepsy therapy: how does cenobamate differ? Epilepsia. 2021;62(3):596–614.
  • Bialer M, Johannessen SI, Levy RH, et al. Progress report on new antiepileptic drugs: a summary of the eleventh eilat conference (EILAT XI). Epilepsy Res. 2013;103(1):2–30.
  • Nakamura M, Cho JH, Shin H, et al. Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons. Eur J Pharmacol. 2019;855:175–182.
  • Sharma R, Nakamura M, Neupane C, et al. Positive allosteric modulation of GABAA receptors by a novel antiepileptic drug cenobamate. Eur J Pharmacol. 2020;879:173117.
  • Guignet M, Campbell A, White HS. Cenobamate (XCOPRI): can preclinical and clinical evidence provide insight into its mechanism of action? Epilepsia. 2020;61(11):2329–2339.
  • Vernillet L, Greene SA, Kamin M. Pharmacokinetics of cenobamate: results from single and multiple oral ascending-dose studies in healthy subjects. Clin Pharmacol Drug Dev. 2020;9(4):428–443.
  • Specchio N, Pietrafusa N, Vigevano F. Is cenobamate the breakthrough we have been wishing for? Int J Mol Sci. 2021;22(17):9339.
  • Prescribing information for XCOPRI. U.S. Food and drug administration 2019 [cited 2020 Jun 28] Available from: https://www.access-data.fda.gov/drugsatfda_docs/label/2019/212839s000lbl.pdf
  • Roberti R, De Caro C, Iannone LF, et al. Pharmacology of cenobamate: mechanism of action, pharmacokinetics, drug-drug interactions and tolerability. CNS Drugs. 2021;35(6):609–618.
  • French JA, Chung SS, Krauss GL, et al. Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: open-label extension of a randomized clinical study. Epilepsia. 2021;62(9):2142–2150.
  • Terapeutics A. Cenobamate [summary of product characteristics]. Amsterdam: Arvelle Therapeutics Netherlands B.V; 2020.
  • Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia. 2007;48(7):1223–1244.
  • Sperling MR, Klein P, Aboumatar S, et al. Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study. Epilepsia. 2020;61(6):1099–1108.
  • Rosenfeld WE, Abou-Khalil B, Aboumatar S, et al. Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: effects of dose adjustments of concomitant antiseizure medications. Epilepsia. 2021;62(12):3016–3028.
  • Bialer M, Johannessen SI, Koepp Mj, et al. Progress report on new antiepileptic drugs: A summary of the Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XV). II. Drugs in more advanced clinical development. Epilepsia. 2020;61(11):2365–2385.
  • Devinsky O, Hesdorffer DC, Thurman DJ, et al. Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention. Lancet Neurol. 2016;15(10):1075–1088.
  • Mula M, Sander JW. Psychosocial aspects of epilepsy: a wider approach. BJPsych Open. 2016;2(4):270–274.
  • Quintas R, Raggi A, Giovannetti AM, et al. Psychosocial difficulties in people with epilepsy: a systematic review of literature from 2005 until 2010. Epilepsy Behav. 2012;25(1):60–67.
  • Zhu L, Chen L, Xu P, et al. Genetic and molecular basis of epilepsy-related cognitive dysfunction. Epilepsy Behav. 2020;104:106848.
  • Elizebath R, Zhang E, Coe P, et al. Cenobamate treatment of focal-onset seizures: quality of life and outcome during up to eight years of treatment. Epilepsy Behav. 2021;116:107796.
  • Steinhoff BJ, Rosenfeld WE, Serratosa JM, et al. Practical guidance for the management of adults receiving adjunctive cenobamate for the treatment of focal epilepsy- expert opinion. Epilepsy Behav. Epilepsy Behav. 2021;123:108270.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.